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Fig 1. Primary aggressive CD81 cytotoxic T-cell (Berti)
lymphoma following adalimumab. Extremity with papu-
losquamous plaques clinically suggestive of psoriasis.
Fig 2. Biopsy of an ulcer on the chest exhibited
an epidermotropic CD81 infiltrate of atypical T-cells.
(Hematoxylin-eosin stain; original magnification 310.)
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reported.4,5 TNF-alpha blockade likely inhibits both
innate and acquired immunity and may compromise
immune surveillance for malignancy.5
The relation between our patient’s dermatitis
and her Berti lymphoma is unclear. Her dermatitis
may have represented a smoldering CTCL that
transformed into Berti lymphoma, or the latter
may have developed anew in the setting of
immunosuppression.
This case suggests that corticosteroid-refractory,
histologically nonspecific dermatitis should be
evaluated carefully and managed cautiously. Not all
psoriasiform dermatitis is psoriasis or is safely treated
as such. A high suspicion for possible CTCL and a
low threshold for repeat biopsies to establish a
diagnosis should be maintained when considering
immunomodulatory therapy.
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To the Editor: A 30-year-old Caucasian woman
presented to the emergency department in June
with a 5-day history of flu-like symptoms. She denied
recent travel from her residence, Columbiana,
Alabama. She was in her usual state of health until
she experienced a tick bite on her forearm 7 days
before admission. Following tick removal, she
noticed fatigue, myalgias, arthralgias, and severe
headache, with retro-orbital pain. A temperature up
to 1058F recalcitrant to antipyretics accompanied her
symptoms.
On examination, the patient was febrile with
a temperature of 105.78F. Although she was
hemodynamically stable, notable laboratory results
included thrombocytopenia ( platelets: 133,000109/L).
No maculopapular rash was noted. An ulcerated
nodule with a central eschar was noted on her right
forearm (Fig 1). The eschar was biopsied by punch
technique with half of the specimen processed
routinely, while the other half was snap frozen in
liquid nitrogen and sent to the Centers for Disease
Control and Prevention (CDC) for further study.
Fig 1. Rickettsia parkeri infection. Clinical image of
cutaneous lesion on right forearm. Ulcerated nodule
with central eschar.
Fig 2. Rickettsia parkeri infection. Histopathology of
cutaneous punch biopsy of eschar. A nodular and diffuse
lymphoid infiltrate permeates the superficial and deep
dermis and extends focally into the subcutaneous fat.
There is overlying ulcer and crust with associated necrosis
extending to the mid dermis. (Hematoxylin-eosin stain;
original magnification: 320.) Inset: Small to medium sized
vessel with lymphocytic vasculitis showing endothelial
swelling and fibrin thrombi (arrowhead ) and perineural
inflammation (arrow). (Hematoxylin-eosin stain; original
magnification: 3200.)
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marked lymphocytic vasculitis with associated ulcer
and dermal necrosis (Fig 2). Polymerase chain
reaction (PCR)-based testing performed at the CDC
was positive for spotted fever group rickettsiae.
Gene sequencing confirmed presence of Rickettsia
parkeri.
The patient’s blood cultures were negative, as
was serologic study for Borrelia burgdorferi andEhrlichia chaffeensis antibodies. No serologic tests
for rickettsial organisms were obtained by primary
team. Treatment in the emergency department
included fluids and doxycycline. She was afebrile
after 3 days on doxycycline and was discharged
home with a 17-day course of doxycycline. She
recovered without sequelae.
Rickettsia parkeri is a spotted fever group
rickettsia first documented in 2004 to cause human
infection.1-3Rickettsia parkeri infections in theUnited
States and South America are a clinical rarity, with 27
cases having been reported in the English litera-
ture.1,4 Other spotted fever group rickettsiae include
Rickettsia felis, Rickettsia 364D, and Rickettsia mas-
siliae. Documented cases reveal a disease that is
milder than classically described Rocky Mountain
spotted fever: typical symptoms include local lymph-
adenopathy, fever, headache, myalgias, inoculation
eschar, and a maculopapular exanthem.5 While
patients with Rocky Mountain spotted fever rarely
present with eschars, R. parkeri has been confused
with Rickettsia akari, a mite-borne causative agent of
eschar-associated rickettsialpox. Even though most
American cases of rickettsialpox have occurred in
inner city areas of northeastern states, recent cases
have been reported in areas endemic to R. parkeri,
such as rural North Carolina.5
Once the broad differential diagnosis of the
febrile patient presenting with eschar has been
narrowed down to the spotted fever group,
diagnostic difficulty remains in obtaining a species-
specific diagnosis. In traditional serologic assays,
antibodies generated to R. parkeri antigens can
cross-react with those of R. rickettsia and R. akari.5
While serology can define a diagnosis in select cases,
an accurate species-specific diagnosis can be made
by sending fresh skin biopsy specimens of the
eschar and rash lesions to an appropriate reference
laboratory for PCR or culture-based assays.1,5 Based
on the literature, we suggest quantitative real-time
PCR targeting the R. parkeri species-specific Rpark
using DNA extracted from eschar specimens to be
the gold standard for diagnosis.1,2
We are indebted to the University of Alabama at
Birmingham Department of Medicine, Division of
Infectious Diseases, and Department of Dermatology for
their administrative support.
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Fig 1. Acute generalized exanthematous pustulosis.
Erythematous, dusky plaques with desquamation and
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pustules over the abdomen. The patient presented with
40% body surface area involvement and progressed to 90%
at time of death.REFERENCES
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http://dx.doi.org/10.1016/j.jaad.2014.03.024Fig 2. Acute generalized exanthematous pustulosis. His-
topathology demonstrates subcorneal pustules without
evidence of epidermal necrosis. (Hematoxylin-eosin stain;
original magnification: 3100.)A rapidly progressive and fatal case of atypical
acute generalized exanthematous pustulosis
To the Editor: A 78-year-old African American
woman with metabolic syndrome presented with
skin sloughing for 2 days. She had no history of
skin conditions. Twelve days before the onset
of the eruption, levofloxacin and vancomycin
were started for presumed pneumonia. Cultures
from the oropharynx revealed methicillin-resistant
Staphylococcus aureus, and the smear was without
neutrophils and contained numerous epithelial cells.
No other medications had been started.
Initial examination revealed erythematous, dusky
plaques and papules with flaccid bullae, and
scattered pustules over approximately 40% of the
body surface area (Fig 1). The vaginal mucosa
appeared erythematous whereas the ocular and
oral mucosae were clear. The initial white blood
cell count was 32.8/L with an absolute neutrophil
count of 28.3/L and a normal eosinophil count.
Pending histopathologic examination, a clinical
diagnosis of toxic epidermal necrolysis (TEN) wasmade, and intravenous immunoglobulin was started
at 1 g/kg/d. Antibiotics were discontinued.
After 24 hours and 1 dose of intravenous immu-
noglobulin, the patient progressed to diffuse
epidermal sloughing with erosions of the oral
mucosa and signs of shock. Intravenous immuno-
globulin was discontinued because of concern for
sepsis or anaphylaxis, and daptomycin, piperacillin-
tazobactam, and fluconazolewere started, alongwith
stress-dose steroids. Skin biopsy specimen from an
area of dusky erythema and pustules demonstrated
subcorneal pustules without epidermal necrosis or
interface alteration (Fig 2). Direct immunofluores-
cence, periodic acideSchiff and Gram stains, and
pustule culture revealed negative findings. The
patient developed multiorgan failure and dissemi-
nated intravascular coagulation, and died on
hospital day 4. Her final cause of death at autopsy
